Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celularity Inc (Class A) | Kok Thay Lim | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 12 Jan 2024 | 21,410,983 | 51,473,762 | - | 0.2 | 5,331,335 | Class A Common Stock |
| Celularity Inc (Class A) | Kok Thay Lim | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Jan 2024 | 16,500,000 | 16,500,000 | - | - | Warrants (Right to Buy) | |
| Celularity Inc (Class A) | Thay Lim Kok | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 6,529,818 | 0 | - | - | Warrants (Right to Buy) | |
| Celularity Inc (Class A) | Thay Lim Kok | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 6,529,818 | 6,529,818 | - | - | Warrants (Right to Buy) | |
| Celularity Inc (Class A) | Kok Thay Lim | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Jan 2024 | 5,352,746 | 5,352,746 | - | - | Warrants (Right to Buy) | |
| New Horizon Aircraft Ltd (Class A) | E. Brandon Robinson | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 2,317,510 | 2,317,510 | - | - | Class A Ordinary Shares | |
| Yext Inc | Walrath Michael | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 1,250,000 | 1,250,000 | - | - | Performance-Based Restricted Stock Unit | |
| Tscan Therapeutics Inc | Gavin MacBeath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 700,000 | 700,000 | - | - | Employee Stock Option (Right to Buy) | |
| GlycoMimetics Inc | Harout Semerjian | Director, Chief Executive Officer | 12 Jan 2024 | 695,000 | 695,000 | - | - | Employee Stock Option (right to buy) | ||
| Scholastic Corp | Iole Lucchese | Director, EVP & CHIEF STRATEGY OFFICER | 12 Jan 2024 | 445,452 | 979,247 (2%) | 1% | - | Common Stock | ||
| Scholastic Corp | Lucchese Iole | Director, EVP & CHIEF STRATEGY OFFICER | 12 Jan 2024 | 445,452 | 445,452 | - | - | Class A Stock | ||
| OLB Grp Inc | Yakov Ronny | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 420,001 | 5,829,702 | - | 0.0 | 42 | Common Stock |
| Arcutis Biotherapeutics Inc | Todd Watanabe Franklin | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| OLB Grp Inc | G Patrick Smith | Vice President - Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 381,069 | 1,023,998 | - | 0.0 | 38 | Common Stock |
| Anixa Biosciences Inc | J. Catelani Michael | President, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 350,000 | 350,000 | - | - | Employee Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Taylor Schreiber H. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 330,100 | 330,100 | - | - | Stock Option (Right to Buy) | |
| New Horizon Aircraft Ltd (Class A) | Jason O’Neill | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 296,000 | 296,000 | - | - | Employee stock option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 276,000 | 276,000 | - | - | Stock Option (right to buy) | |
| OLB Grp Inc | Patrick Smith G | Vice President - Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 275,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| CorMedix Inc | Todisco Joseph | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 266,667 | 266,667 | - | - | Stock Option (Right to Buy Common Stock) | |
| New Horizon Aircraft Ltd (Class A) | Stewart Lee | Head of People & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 250,042 | 250,042 | - | - | Class A Ordinary Shares | |
| GlycoMimetics Inc | Hahn M. Brian | SVP Finance, CFO | 12 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| GlycoMimetics Inc | Rath Chinmaya | SVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| GlycoMimetics Inc | Johnson S. Bruce | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| GlycoMimetics Inc | Rock Edwin | Chief Medical Officer | 12 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| New Horizon Aircraft Ltd (Class A) | Jason O’Neill | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 235,522 | 235,522 | - | - | Class A Ordinary Shares without par value | |
| Outset Medical Inc | L. Trigg Leslie | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 212,500 | 601,599 | - | 0 | Common Stock | |
| OLB Grp Inc | Yakov Ronny | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 200,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| OLB Grp Inc | Ronny Yakov | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 200,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Outset Medical Inc | L. Trigg Leslie | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 200,000 | 801,599 | - | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Todd Edwards Larry | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 176,000 | 176,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Matsuda Masaru | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 176,000 | 176,000 | - | - | Stock Option (right to buy) | |
| Tscan Therapeutics Inc | Gavin MacBeath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| New Horizon Aircraft Ltd (Class A) | Jason O’Neill | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 146,252 | 146,252 | - | - | Employee stock option (right to buy) | |
| Taboola.com Ltd | Eldad Maniv | President and COO | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 12 Jan 2024 | 144,263 | 9,028,345 | - | 4.1 | 588,593 | Ordinary Shares |
| New Horizon Aircraft Ltd (Class A) | E. Brandon Robinson | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 143,213 | 143,213 | - | - | Employee Stock Option (Right to Buy) | |
| Outset Medical Inc | Ahmed Nabeel | Chief Financial Officer | 12 Jan 2024 | 136,000 | 212,819 | - | 0 | Common Stock | ||
| CorMedix Inc | Todisco Joseph | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 133,333 | 353,059 (1%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Richard Matthew Moore | SVP and Chief Business Officer | 12 Jan 2024 | 126,000 | 126,000 | - | - | Stock Option (Right to Buy) | ||
| Arcutis Biotherapeutics Inc | Watanabe Todd Franklin | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 125,000 | 627,019 (1%) | 0% | 0 | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 113,406 | 423,098 (0%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 113,406 | 0 | - | - | Restricted Stock Units (2020) | |
| Outset Medical Inc | Williamson Steven | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 112,000 | 217,939 | - | 0 | Common Stock | |
| OLB Grp Inc | Patrick Smith G | Vice President - Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 106,069 | 159,103 | - | - | Employee Stock Option (right to buy) | |
| MP Materials Corp | Litinsky H. James | Director, Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 105,264 | 530,195 | - | 0 | Common Stock | |
| CorMedix Inc | David Matthew T. | Chief Financial Officer | 12 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Common Stock) | ||
| CorMedix Inc | Mistry Erin | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Outset Medical Inc | Nash Marc | SVP Operations and R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 241,233 | - | 0 | Common Stock | |
| Outset Medical Inc | Racine Jean-Olivier | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 269,781 | - | 0 | Common Stock | |
| Outset Medical Inc | Williamson Steven | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 317,939 | - | 0 | Common Stock | |
| Outset Medical Inc | John Brottem L. | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 244,807 | - | 0 | Common Stock | |
| Outset Medical Inc | Nabeel Ahmed | Chief Financial Officer | 12 Jan 2024 | 100,000 | 312,819 | - | 0 | Common Stock | ||
| Praxis Precision Medicines Inc | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Outset Medical Inc | Nash Marc | SVP Operations and R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 96,000 | 141,233 | - | 0 | Common Stock | |
| Outset Medical Inc | Brottem John L. | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 96,000 | 144,807 | - | 0 | Common Stock | |
| Outset Medical Inc | Jean-Olivier Racine | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 96,000 | 169,781 | - | 0 | Common Stock | |
| Coinbase Global Inc (Class A) | Choi M. Emilie | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 80,396 | 276,064 | - | 0 | Class A Common Stock | |
| Coinbase Global Inc (Class A) | M. Emilie Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 80,396 | 0 | - | - | Restricted Stock Units | |
| Coinbase Global Inc (Class A) | Choi M. Emilie | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 80,396 | 80,396 | - | - | Restricted Stock Units | |
| MP Materials Corp | Michael Rosenthal | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 77,158 | 1,544,437 | - | 0 | Common Stock | |
| Taboola.com Ltd | Maniv Eldad | President and COO | Sale of securities on an exchange or to another person at price $ 4.19 per share. | 12 Jan 2024 | 74,968 | 9,172,608 | - | 4.2 | 314,116 | Ordinary Shares |
| MP Materials Corp | Ryan Corbett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 74,347 | 375,310 | - | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 74,160 | 876,748 (2%) | 0% | 0 | Common Stock | |
| New Horizon Aircraft Ltd (Class A) | Jason O’Neill | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 74,000 | 74,000 | - | - | Performance Stock Units | |
| DexCom | R. Sayer Kevin | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 72,709 | 400,166 (0%) | 0% | 0.0 | 73 | Common Stock |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 66,185 | 519,835 (0%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 66,185 | 132,372 | - | - | Restricted Stock Units (2023) | |
| Ideaya Biosciences Inc | S. Hata Yujiro | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 62,739 | 324,454 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Yujiro Hata S. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 40.17 per share. | 12 Jan 2024 | 62,739 | 677,887 (3%) | 0% | 40.2 | 2,519,968 | Common Stock |
| Ideaya Biosciences Inc | S. Hata Yujiro | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 12 Jan 2024 | 62,739 | 740,626 (3%) | 0% | 4.3 | 270,405 | Common Stock |
| Credo Tech Grp Holding Ltd | Cheng Fung Chi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 19.20 per share. | 12 Jan 2024 | 60,000 | 10,708,602 | - | 19.2 | 1,151,826 | Ordinary Shares |
| NexPoint Diversified Real Estate Trust | Dondero James D. | Director, See Remarks, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 57,847 | 485,130 (1%) | 0% | - | Common Stock | |
| NexPoint Diversified Real Estate Trust | Dondero D. James | Director, See Remarks, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 56,455 | 597,203 (1%) | 0% | - | Common Stock | |
| NexPoint Diversified Real Estate Trust | D. James Dondero | Director, See Remarks, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 55,617 | 540,748 (1%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 54,794 | 473,924 (0%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 54,794 | 54,794 | - | - | Restricted Stock Units (2022) | |
| Tilray Brands Inc | Irwin Simon D. | President and CEO | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 12 Jan 2024 | 53,700 | 2,033,058 | - | 1.9 | 100,956 | Common Stock |
| Joby Aviation Inc | Eric Allison | Head of Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 53,549 | 421,064 | - | 0 | Common Stock | |
| Joby Aviation Inc | Eric Allison | Head of Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 53,549 | 642,587 | - | - | Restricted Stock Units (RSUs) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Sun Communities Inc | Shiffman Gary A. | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jan 2024 | 50,307 | 914,740 (0%) | 0% | 0 | COMMON STOCK, $0.01 PAR VALUE | |
| Sun Communities Inc | A. Shiffman Gary | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jan 2024 | 50,307 | 897,881 (0%) | 0% | 0 | COMMON STOCK, $0.01 PAR VALUE | |
| BTCS Inc | Prevoznik Michael | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 471,486 | - | - | Common Stock | |
| BTCS Inc | Paranjape Manish | CTO | 12 Jan 2024 | 50,000 | 402,444 | - | - | Common Stock | ||
| BTCS Inc | Handerhan Michal | Director, COO, Ten Percent Owner | 12 Jan 2024 | 50,000 | 1,763,878 | - | - | Common Stock | ||
| BTCS Inc | Allen Charles W. | Director, CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 4,314,220 | - | - | Common Stock | |
| CorMedix Inc | Erin Mistry | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 54,900 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | David T. Matthew | Chief Financial Officer | 12 Jan 2024 | 50,000 | 53,150 (0%) | 0% | 0 | Common Stock | ||
| Olema Pharma Inc | Kovacs Shane | CH. OPERATING & FINANCIAL OFF. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 187,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 12 Jan 2024 | 50,000 | 484,987 | - | 7.0 | 351,000 | Common Stock |
| Research Soln Inc | Barbara J. Cooperman | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 0 | - | - | Option to purchase common stock | |
| Research Soln Inc | J. Barbara Cooperman | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 50,000 | - | - | Option to purchase common stock | |
| Research Soln Inc | J. Cooperman Barbara | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 0 | - | - | Option to purchase common stock | |
| Research Soln Inc | Barbara J. Cooperman | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 50,000 | - | - | Option to purchase common stock | |
| Tscan Therapeutics Inc | Leiden Dworak | Vice President, Finance | 12 Jan 2024 | 46,875 | 46,875 | - | - | Stock Option (Right to Buy) | ||
| MP Materials Corp | Dean Elliot Hoops | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 45,997 | 86,811 | - | 0 | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 45,889 | 436,109 (0%) | 0% | - | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 45,889 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 45,510 | 281,882 (0%) | 0% | - | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 45,510 | 0 | - | - | Restricted Stock Units (2020) | |
| Outset Medical Inc | L. Trigg Leslie | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 44,938 | 846,537 | - | 0 | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 41,979 | 109,669 (0%) | 0% | - | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 41,979 | 0 | - | - | Restricted Stock Units (2020) | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 40,588 | 332,928 (0%) | 0% | - | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 40,588 | 40,590 | - | - | Restricted Stock Units (2022) | |
| Coinbase Global Inc (Class A) | Choi M. Emilie | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.78 per share. | 12 Jan 2024 | 39,922 | 236,142 | - | 130.8 | 5,220,999 | Class A Common Stock |
| TKO (Class A) | Krauss Seth D. | Chief Legal & Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 39,109 | 39,109 | - | - | Restricted Stock Units | |
| Research Soln Inc | Barbara J. Cooperman | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 38,767 | 0 | - | - | Option to purchase common stock | |
| Research Soln Inc | Barbara Cooperman J. | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 38,767 | 38,767 | - | - | Option to purchase common stock | |
| DexCom | R. Sayer Kevin | Director, President, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 12 Jan 2024 | 37,325 | 362,841 (0%) | 0% | 123.6 | 4,614,669 | Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 36,101 | 72,203 | - | - | Restricted Stock Units (2023) | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 36,101 | 354,011 (0%) | 0% | - | Common Stock | |
| NVIDIA | Stevens Mark A. | Director | Sale of securities on an exchange or to another person at price $ 546.95 per share. | 12 Jan 2024 | 36,000 | 1,134,583 (0%) | 0% | 547.0 | 19,690,344 | Common Stock |
| New Horizon Aircraft Ltd (Class A) | Stewart Lee | Head of People & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 35,455 | 35,455 | - | - | Employee Stock Option (Right to Buy) | |
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 32,878 | 390,220 (0%) | 0% | 16.5 | 541,829 | Common Stock |
| American International | S. Peter Zaffino | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.50 per share. | 12 Jan 2024 | 31,074 | 371,373 (0%) | 0% | 67.5 | 2,097,495 | Common Stock |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 30,442 | 371,351 (0%) | 0% | - | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 30,442 | 30,440 | - | - | Restricted Stock Units (2022) | |
| Flagstar Fin Inc | Cangemi Thomas R. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Jan 2024 | 30,323 | 1,152,400 (0%) | 0% | 0 | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 30,084 | 60,169 | - | - | Restricted Stock Units (2023) | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 30,084 | 394,737 (0%) | 0% | - | Common Stock | |
| Praxis Precision Medicines Inc | Nemiroff Alex | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Kelly Timothy E. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Charter (Class A) | Winfrey Christopher | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,911 | 0 | - | - | Stock Options | |
| Charter (Class A) | Winfrey Christopher | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 150.88 per share. | 12 Jan 2024 | 28,911 | 72,814 (0%) | 0% | 150.9 | 4,362,092 | Class A Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,893 | 300,762 (0%) | 0% | - | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,893 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,078 | 56,159 | - | - | Restricted Stock Units (2023) | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,078 | 160,281 (0%) | 0% | - | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,052 | 143,141 (0%) | 0% | - | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 28,052 | 0 | - | - | Restricted Stock Units (2020) | |
| Arcutis Biotherapeutics Inc | Richard Matthew Moore | SVP and Chief Business Officer | 12 Jan 2024 | 28,000 | 54,590 (0%) | 0% | 0 | Common Stock | ||
| Arcutis Biotherapeutics Inc | Burnett Patrick | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 28,000 | 85,032 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Matsuda Masaru | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 28,000 | 74,634 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Todd Edwards Larry | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 28,000 | 88,000 (0%) | 0% | 0 | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 27,803 | 142,421 (0%) | 0% | - | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 27,803 | 27,803 | - | - | Restricted Stock Units (2022) | |
| Vital Farms Inc | Russell Diez-Canseco | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 27,500 | 167,178 | - | - | Employee Stock Option (right to buy) | |
| Vital Farms Inc | Diez-Canseco Russell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share. | 12 Jan 2024 | 27,500 | 246,156 | - | 3.7 | 101,057 | Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 26,585 | 26,586 | - | - | Restricted Stock Units (2022) | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 26,585 | 259,913 (0%) | 0% | - | Common Stock | |
| Vital Farms Inc | Russell Diez-Canseco | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.23 per share. | 12 Jan 2024 | 26,096 | 220,060 | - | 15.2 | 397,442 | Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 25,698 | 221,616 (0%) | 0% | - | Common Stock | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 25,698 | 0 | - | - | Restricted Stock Units (2020) | |
| Community Healthcare Trust Inc | H. David Dupuy | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 26.04 per share. | 12 Jan 2024 | 25,602 | 354,616 (1%) | 0% | 26.0 | 666,676 | Common Stock |
| Anixa Biosciences Inc | Emily Gottschalk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Baskies Arnold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 24,489 | 495,346 (0%) | 0% | 16.5 | 403,579 | Common Stock |
| IDT Corp (Class B) | Bill Pereira | Director, COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 23,500 | 23,500 | - | - | Deferred Stock Units | |
| Agenus Inc | Garo Armen H. | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.64 per share. | 12 Jan 2024 | 23,177 | 1,439,261 (1%) | 0% | 0.6 | 14,833 | Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 22,426 | 170,066 (0%) | 0% | - | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 22,426 | 22,426 | - | - | Restricted Stock Units (2022) | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 22,265 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 22,265 | 238,227 (0%) | 0% | - | Common Stock | |
| One Liberty Properties Inc | J. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 21,750 | 377,693 (1%) | 0% | 0 | Common Stock | |
| Coinbase Global Inc (Class A) | Ernest Frederick Ehrsam | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 132.80 per share. | 12 Jan 2024 | 20,961 | 349,022 | - | 132.8 | 2,783,516 | Class A Common Stock |
| Barfresh Food Grp Inc | Ortiz-Cochet Isabelle | Director | 12 Jan 2024 | 20,886 | 20,886 | - | - | Stock option | ||
| Barfresh Food Grp Inc | Steven Lang | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 20,886 | 20,886 | - | - | Stock option | |
| Joby Aviation Inc | Eric Allison | Head of Product | Sale of securities on an exchange or to another person at price $ 5.73 per share. | 12 Jan 2024 | 20,753 | 400,311 | - | 5.7 | 118,915 | Common Stock |
| Charter (Class A) | Christopher Winfrey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 364.90 per share. | 12 Jan 2024 | 20,630 | 52,184 (0%) | 0% | 364.9 | 7,527,887 | Class A Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 20,557 | 41,117 | - | - | Restricted Stock Units (2023) | |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 20,557 | 185,155 (0%) | 0% | - | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 20,547 | 345,430 (0%) | 0% | - | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 20,547 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 20,427 | 68,821 (0%) | 0% | - | Common Stock | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 20,427 | 0 | - | - | Restricted Stock Units (2020) | |
| Ionis Pharma Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 12 Jan 2024 | 20,400 | 60,470 | - | - | Restricted Stock Unit | ||
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 20,274 | 453,650 (0%) | 0% | 16.5 | 334,116 | Common Stock |
| Tilray Brands Inc | Merton Carl | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 12 Jan 2024 | 20,000 | 20,000 | - | 1.9 | 37,400 | Common Stock |
| Cognizant (Class A) | Singisetti Ravi Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 19,201 | 54,168 (0%) | 0% | - | Class A Common Stock | |
| Cognizant (Class A) | Ravi Kumar Singisetti | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 19,201 | 0 | - | - | Restricted Stock Units | |
| Coinbase Global Inc (Class A) | Frederick Ehrsam Ernest | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 132.05 per share. | 12 Jan 2024 | 19,162 | 369,983 | - | 132.0 | 2,530,258 | Class A Common Stock |
| Community Healthcare Trust Inc | Monroe G. William | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 26.04 per share. | 12 Jan 2024 | 18,987 | 67,567 (0%) | 0% | 26.0 | 494,421 | Common Stock |
| Walmart | C. Douglas McMillon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 18,900 | 1,434,532 (0%) | 0% | 0 | Common Stock | |
| Interface Inc | Laurel Hurd M. | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.04 per share. | 12 Jan 2024 | 18,723 | 243,946 (0%) | 0% | 12.0 | 225,425 | Common Stock |
| 3D Systems Corp | Jeffrey Graves A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 18,519 | 751,975 (0%) | 0% | 5.2 | 96,114 | Common Stock |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 18,186 | 118,619 (0%) | 0% | - | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 18,186 | 0 | - | - | Restricted Stock Units (2021) | |
| Caredx Inc | Michael Goldberg D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 18,165 | 121,016 (0%) | 0% | 0 | Common Stock | |
| American International | Hancock Jonathan | EVP & CEO, Intl Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.50 per share. | 12 Jan 2024 | 18,158 | 47,404 (0%) | 0% | 67.5 | 1,225,665 | Common Stock |
| Walmart | R. John Furner | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 17,325 | 264,616 (0%) | 0% | 0 | Common | |
| Walmart | Suresh Kumar | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 17,325 | 488,859 (0%) | 0% | 0 | Common | |
| Barfresh Food Grp Inc | Arnold Tinter | Director, Secretary | 12 Jan 2024 | 17,241 | 50,574 | - | - | Common Stock | ||
| Barfresh Food Grp Inc | Alexander H. Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 17,241 | 111,848 | - | - | Common Stock | |
| Barfresh Food Grp Inc | M. Cugine Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 17,241 | 219,663 | - | - | Common Stock | |
| Cardlytics Inc | Clifford Sosin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 12 Jan 2024 | 17,155 | 5,361,961 (20%) | 0% | 7.0 | 120,128 | Common Stock |
| One Liberty Properties Inc | G. Lawrence Ricketts | Exec.Vice President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 17,100 | 192,100 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 12 Jan 2024 | 17,000 | 43,437 | - | - | Performance Restricted Stock Units | ||
| Genpact Ltd | Kathryn A. Stein | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.80 per share. | 12 Jan 2024 | 16,998 | 47,593 (0%) | 0% | 34.8 | 591,530 | Common Shares |
| AT&T | John T. Stankey | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 16,979 | 419,130 (0%) | 0% | 16.5 | 279,814 | Common Stock |
| Walmart | McLay Kathryn | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 16,538 | 274,428 (0%) | 0% | 0 | Common | |
| Service Corp Intl | Eric Tanzberger D. | Sr. VP, and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.58 per share. | 12 Jan 2024 | 16,468 | 30,250 (0%) | 0% | 66.6 | 1,096,439 | Common Stock |
| Joby Aviation Inc | Kate DeHoff | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 16,065 | 192,777 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Kate DeHoff | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 16,065 | 179,338 | - | 0 | Common Stock | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 16,022 | 16,020 | - | - | Restricted Stock Units (2022) | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 16,022 | 243,930 (0%) | 0% | - | Common Stock | |
| Sun Communities Inc | Shiffman A. Gary | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jan 2024 | 15,993 | 930,733 (0%) | 0% | 0 | COMMON STOCK, $0.01 PAR VALUE | |
| Sun Communities Inc | Shiffman A. Gary | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jan 2024 | 15,993 | 913,874 (0%) | 0% | 0 | COMMON STOCK, $0.01 PAR VALUE | |
| Kilroy Realty Corp | Kilroy John B. | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 12 Jan 2024 | 15,334 | 766,419 (0%) | 0% | 40.5 | 621,027 | Common stock, par value $0.01 per share |
| Service Corp Intl | Ryan Thomas L. | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.58 per share. | 12 Jan 2024 | 15,244 | 450,700 (0%) | 0% | 66.6 | 1,014,946 | Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 15,018 | 317,910 (0%) | 0% | 16.5 | 247,497 | Common Stock |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 14,756 | 81,931 (0%) | 0% | - | Common Stock | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 14,756 | 14,757 | - | - | Restricted Stock Units (2022) | |
| Walmart | David Rainey John | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 14,569 | 177,871 (0%) | 0% | 0 | Common | |
| Genesco Inc | I. Gray Andrew | Senior VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 14,472 | 14,472 (0%) | 0% | 0 | Common Stock | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 14,166 | 28,334 | - | - | Restricted Stock Units (2023) | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 14,166 | 91,655 (0%) | 0% | - | Common Stock | |
| CorMedix Inc | Joseph Todisco | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 12 Jan 2024 | 13,781 | 339,278 (1%) | 0% | 3.5 | 47,820 | Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 13,682 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 13,682 | 150,651 (0%) | 0% | - | Common Stock | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 13,541 | 27,084 | - | - | Restricted Stock Units (2023) | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 13,541 | 252,690 (0%) | 0% | - | Common Stock | |
| Community Healthcare Trust Inc | Timothy L. Meyer | EVP - Asset Management | 12 Jan 2024 | 13,432 | 154,158 (0%) | 0% | 26.0 | 349,769 | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 13,358 | 340,653 (0%) | 0% | 16.5 | 220,140 | Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 13,137 | 26,274 | - | - | Restricted Stock Units (2023) | |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 13,137 | 265,115 (0%) | 0% | - | Common Stock | |
| Build A Bear Workshop Inc | Price John Sharon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.27 per share. | 12 Jan 2024 | 12,432 | 590,349 (3%) | 0% | 22.3 | 276,844 | Common Stock |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 12,415 | 150,850 (0%) | 0% | - | Common Stock | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 12,415 | 0 | - | - | Restricted Stock Units (2021) | |
| Ideaya Biosciences Inc | Hata Yujiro S. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 40.04 per share. | 12 Jan 2024 | 12,261 | 677,887 (3%) | 0% | 40.0 | 490,913 | Common Stock |
| Ideaya Biosciences Inc | S. Yujiro Hata | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 12,261 | 387,193 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Yujiro Hata S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 12 Jan 2024 | 12,261 | 690,148 (3%) | 0% | 4.3 | 52,845 | Common Stock |
| One Liberty Properties Inc | Matthew Gould J. | Director, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 12,000 | 331,031 (1%) | 0% | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 12 Jan 2024 | 11,976 | 11,976 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 12 Jan 2024 | 11,976 | 1,623,192 | - | - | Class B Common Stock | ||
| Cerence Inc | Stefan Ortmanns | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.26 per share. | 12 Jan 2024 | 11,942 | 573,985 (1%) | 0% | 19.3 | 230,003 | Common Stock |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 11,806 | 11,804 | - | - | Restricted Stock Units (2022) | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 11,806 | 161,524 (0%) | 0% | - | Common Stock | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 12 Jan 2024 | 11,660 | 173,472 (0%) | 0% | 60 | 699,600 | Common Stock |
| Cadence Design | Alberto Vincentelli Sangiovanni | Director | Sale of securities on an exchange or to another person at price $ 267.67 per share. | 12 Jan 2024 | 11,500 | 59,183 (0%) | 0% | 267.7 | 3,078,205 | Common Stock |
| Community Healthcare Trust Inc | Ann Leigh Stach | Executive Vice President & CAO | Grant, award, or other acquisition of securities at price $ 26.04 per share. | 12 Jan 2024 | 11,473 | 375,592 (1%) | 0% | 26.0 | 298,757 | Common Stock |
| Coinbase Global Inc (Class A) | Ernest Ehrsam Frederick | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 135.94 per share. | 12 Jan 2024 | 11,301 | 320,303 | - | 135.9 | 1,536,213 | Class A Common Stock |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 11,300 | 228,511 (0%) | 0% | - | Common Stock | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 11,300 | 0 | - | - | Restricted Stock Units (2021) | |
| Velocity Fin Inc | Jeffrey T. Taylor | Executive VP, Capital Markets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 12 Jan 2024 | 11,146 | 102,134 (0%) | 0% | 16.0 | 178,559 | Common Stock |
| Walmart | Christopher Nicholas | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 11,025 | 125,636 (0%) | 0% | 0 | Common | |
| Velocity Fin Inc | Mark R. Szczepaniak | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 12 Jan 2024 | 10,686 | 92,325 (0%) | 0% | 16.0 | 171,190 | Common Stock |
| Flagstar Fin Inc | J. John Pinto | Sr EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Jan 2024 | 10,440 | 487,872 (0%) | 0% | 0 | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 10,389 | 149,892 (0%) | 0% | 16.5 | 171,211 | Common Stock |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 10,218 | 132,203 (0%) | 0% | 16.5 | 168,393 | Common Stock |
| American International | McElroy David | EVP, Chairman, General Ins | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.50 per share. | 12 Jan 2024 | 10,132 | 70,259 (0%) | 0% | 67.5 | 683,910 | Common Stock |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 10,013 | 271,869 (0%) | 0% | 16.5 | 165,014 | Common Stock |
| Edwards Lifesciences | Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 10,000 | 38,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 12 Jan 2024 | 10,000 | 49,502 (0%) | 0% | 36.8 | 367,500 | Common Stock |
| Edwards Lifesciences | E. Donald Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 75.67 per share. | 12 Jan 2024 | 10,000 | 39,502 (0%) | 0% | 75.7 | 756,700 | Common Stock |
| ACM Research Inc (Class A) | Mark McKechnie | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.55 per share. | 12 Jan 2024 | 10,000 | 10,900 (0%) | 0% | 4.6 | 45,500 | Class A Common Stock |
| ACM Research Inc (Class A) | McKechnie Mark | See Remarks | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 12 Jan 2024 | 10,000 | 900 (0%) | 0% | 22 | 220,000 | Class A Common Stock |
| ACM Research Inc (Class A) | McKechnie Mark | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 10,000 | 8,750 | - | - | Stock Option | |
| Cadence Design | Vincentelli Alberto Sangiovanni | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.81 per share. | 12 Jan 2024 | 10,000 | 70,683 (0%) | 0% | 13.8 | 138,100 | Common Stock |
| Cadence Design | Sangiovanni Vincentelli Alberto | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 10,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
| JFrog Ltd | Landman Yoav | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 33.03 per share. | 12 Jan 2024 | 10,000 | 6,989,407 | - | 33.0 | 330,254 | Ordinary Shares |
| One Liberty Properties Inc | Mark Lundy H. | Sr. VP & Asst Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 9,800 | 204,728 (1%) | 0% | 0 | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 9,701 | 385,036 (0%) | 0% | 16.5 | 159,872 | Common Stock |
| DexCom | Leach Jake | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 9,697 | 266,477 (0%) | 0% | 0.0 | 10 | Common Stock |
| Entera Bio Ltd | Haya Taitel | Director | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 12 Jan 2024 | 9,500 | 35,115 (0%) | 0% | 1.0 | 9,405 | Ordinary Shares, par value NIS 0.0000769 per share |
| Kura Sushi USA Inc (Class A) | Brent Takao | See Remarks (a) | Sale of securities on an exchange or to another person at price $ 88.82 per share. | 12 Jan 2024 | 9,422 | 1,687 | - | 88.8 | 836,819 | Class A Common Stock |
| Kura Sushi USA Inc (Class A) | Brent Takao | See Remarks (a) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 9,422 | 10,578 | - | - | Option to Purchase Class A Common Stock | |
| Kura Sushi USA Inc (Class A) | Brent Takao | See Remarks (a) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.94 per share. | 12 Jan 2024 | 9,422 | 11,109 | - | 25.9 | 244,407 | Class A Common Stock |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 9,236 | 100,433 (0%) | 0% | 16.5 | 152,209 | Common Stock |
| Verastem Inc | Robert Gagnon | Director | 12 Jan 2024 | 9,204 | 37,008 (0%) | 0% | 11.0 | 100,784 | Common Stock | |
| Coinbase Global Inc (Class A) | Frederick Ernest Ehrsam | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 133.99 per share. | 12 Jan 2024 | 9,190 | 339,832 | - | 134.0 | 1,231,381 | Class A Common Stock |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 9,166 | 18,334 | - | - | Restricted Stock Units (2023) | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 9,166 | 167,815 (0%) | 0% | - | Common Stock | |
| Hercules Cap Inc | Scott Bluestein | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.58 per share. | 12 Jan 2024 | 9,044 | 2,305,061 (2%) | 0% | 17.6 | 158,994 | Common Stock |
| Universal Insurance Holdings Inc | J. Stephen Donaghy | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jan 2024 | 9,000 | 697,051 (2%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Fredric H. Gould | Director, Vice Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 8,800 | 578,748 (2%) | 0% | 0 | Common Stock | |
| Walmart | Donna Morris | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 8,663 | 127,852 (0%) | 0% | 0 | Common | |
| Cognizant (Class A) | Ravi Kumar Singisetti | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.97 per share. | 12 Jan 2024 | 8,652 | 45,516 (0%) | 0% | 78.0 | 674,596 | Class A Common Stock |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 8,475 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 8,475 | 141,880 (0%) | 0% | - | Common Stock | |
| AT&T | Jeffery S. McElfresh | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 8,422 | 292,340 (0%) | 0% | 16.5 | 138,795 | Common Stock |
| Coinbase Global Inc (Class A) | Frederick Ernest Ehrsam | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 136.88 per share. | 12 Jan 2024 | 8,400 | 311,903 | - | 136.9 | 1,149,811 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Frederick Ehrsam Ernest | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 130.85 per share. | 12 Jan 2024 | 8,271 | 389,145 | - | 130.9 | 1,082,261 | Class A Common Stock |
| Walmart | Brand Rachel | Executive Vice President | 12 Jan 2024 | 8,269 | 171,670 (0%) | 0% | 0 | Common | ||
| Walmart | J. Daniel Bartlett | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 8,269 | 164,402 (0%) | 0% | 0 | Common Stock | |
| Coinbase Global Inc (Class A) | Frederick Ehrsam Ernest | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 134.83 per share. | 12 Jan 2024 | 8,228 | 331,604 | - | 134.8 | 1,109,398 | Class A Common Stock |
| American International | Christopher Schaper | EVP, Glbl Chf Underwriting Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.50 per share. | 12 Jan 2024 | 8,201 | 50,025 (0%) | 0% | 67.5 | 553,568 | Common Stock |
| Outset Medical Inc | Leslie Trigg L. | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 4.29 per share. | 12 Jan 2024 | 8,126 | 838,411 | - | 4.3 | 34,861 | Common Stock |
| Charter (Class A) | Winfrey Christopher | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 150.88 per share. | 12 Jan 2024 | 8,065 | 46,450 (0%) | 0% | 150.9 | 1,216,847 | Class A Common Stock |
| Charter (Class A) | Christopher Winfrey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 8,065 | 0 | - | - | Stock Options | |
| Ionis Pharma Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 12 Jan 2024 | 8,000 | 46,170 (0%) | 0% | 32.6 | 260,800 | Common Stock | |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 12 Jan 2024 | 8,000 | 38,170 (0%) | 0% | 53.5 | 427,999 | Common Stock | |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 12 Jan 2024 | 8,000 | 24,265 | - | - | Non-Qualified Stock Option (right to buy) | ||
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 7,935 | 251,978 (0%) | 0% | 16.5 | 130,769 | Common Stock |
| American International | Bolt Thomas | EVP and Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.50 per share. | 12 Jan 2024 | 7,660 | 53,971 (0%) | 0% | 67.5 | 517,050 | Common Stock |
| DexCom | Sadie Stern | EVP Chief Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 7,620 | 81,953 (0%) | 0% | 0.0 | 8 | Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 7,607 | 177,548 (0%) | 0% | 16.5 | 125,363 | Common Stock |
| One Liberty Properties Inc | Kalish Isaac | Sr Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 7,500 | 78,870 (0%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | W. David Kalish | Senior VP - Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 7,500 | 227,884 (1%) | 0% | 0 | Common Stock | |
| DexCom | Jereme Sylvain M. | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 7,171 | 77,239 (0%) | 0% | 0.0 | 7 | Common Stock |
| AT&T | Sabrina Sanders | SVP-ChiefActngOfcr&Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 7,083 | 14,167 | - | - | Restricted Stock Units (2023) | |
| AT&T | Sabrina Sanders | SVP-ChiefActngOfcr&Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 7,083 | 121,628 (0%) | 0% | - | Common Stock | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 7,062 | 69,301 (0%) | 0% | - | Common Stock | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 7,062 | 0 | - | - | Restricted Stock Units (2021) | |
| Blend Labs Inc (Class A) | Jafari Amir | Head of Finance and Admin. | 12 Jan 2024 | 7,002 | 75,559 | - | 2.4 | 16,981 | Class A Common Stock | |
| 3D Systems Corp | Puthenveetil Reji | EVP, Additive Solutions & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 6,929 | 256,089 (0%) | 0% | 5.2 | 35,962 | Common Stock |
| Caterpillar | D. Anthony Fassino | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 6,887 | 23,152 (0%) | 0% | 0 | Common Stock | |
| Caterpillar | De Lange Bob | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 6,887 | 61,092 (0%) | 0% | 0 | Common Stock | |
| Caterpillar | Denise C. Johnson | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 6,887 | 24,855 (0%) | 0% | 0 | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 6,698 | 364,653 (0%) | 0% | 16.5 | 110,383 | Common Stock |
| OLB Grp Inc | Yakov Ronny | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 6,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| OLB Grp Inc | Ronny Yakov | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 6,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| OLB Grp Inc | Ronny Yakov | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 6,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 6,582 | 62,239 (0%) | 0% | 16.5 | 108,471 | Common Stock |
| Salesforce | Benioff Marc | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 272.63 per share. | 12 Jan 2024 | 6,548 | 13,810,768 (1%) | 0% | 272.6 | 1,785,164 | Common Stock |
| Interface Inc | Bruce Hausmann Andrew | VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.04 per share. | 12 Jan 2024 | 6,443 | 236,375 (0%) | 0% | 12.0 | 77,574 | Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 6,172 | 136,969 (0%) | 0% | 16.5 | 101,715 | Common Stock |
| Build A Bear Workshop Inc | Price John Sharon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 12 Jan 2024 | 6,144 | 584,205 (3%) | 0% | 22.0 | 135,307 | Common Stock |
| Joby Aviation Inc | DeHoff Kate | See Remarks | Sale of securities on an exchange or to another person at price $ 5.73 per share. | 12 Jan 2024 | 6,130 | 173,208 | - | 5.7 | 35,125 | Common Stock |
| One Liberty Properties Inc | Clair Justin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 6,000 | 49,749 (0%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | Nabeel Ahmed | Chief Financial Officer | 12 Jan 2024 | 5,904 | 318,723 | - | 0 | Common Stock | ||
| Outset Medical Inc | Williamson Steven | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 5,904 | 323,843 | - | 0 | Common Stock | |
| Velocity Fin Inc | T. Roland Kelly | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 12 Jan 2024 | 5,806 | 62,758 (0%) | 0% | 16.0 | 93,012 | Common Stock |
| Charter (Class A) | Christopher Winfrey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 364.90 per share. | 12 Jan 2024 | 5,752 | 40,698 (0%) | 0% | 364.9 | 2,098,905 | Class A Common Stock |
| 3D Systems Corp | Ellis Menno | EVP, Healthcare Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 5,724 | 206,267 (0%) | 0% | 5.2 | 29,708 | Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 5,654 | 215,962 (0%) | 0% | 16.5 | 93,178 | Common Stock |
| 3D Systems Corp | M. Andrew Johnson | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 5,627 | 206,186 (0%) | 0% | 5.2 | 29,204 | Common Stock |
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 374.30 per share. | 12 Jan 2024 | 5,588 | 3,588 (0%) | 0% | 374.3 | 2,091,614 | Class A Common Stock |
| Kohl`s Corp | Arlin Wendy C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 5,551 | 5,551 (0%) | 0% | - | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofcr & SEVP Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 5,468 | 164,598 (0%) | 0% | 16.5 | 90,113 | Common Stock |
| Interface Inc | Nigel Stansfield | Vice President | 12 Jan 2024 | 5,457 | 192,864 (0%) | 0% | 12.0 | 65,702 | Common Stock | |
| Tilray Brands Inc | S. Gendel Mitchell | Global General Counsel | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 12 Jan 2024 | 5,400 | 188,596 | - | 1.9 | 10,098 | Common Stock |
| Insmed Inc | Adsett Roger | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 28.63 per share. | 12 Jan 2024 | 5,251 | 148,559 (0%) | 0% | 28.6 | 150,336 | Common Stock |
| CorMedix Inc | Matthew T. David | Chief Financial Officer | 12 Jan 2024 | 5,216 | 47,934 (0%) | 0% | 3.5 | 18,100 | Common Stock | |
| One Liberty Properties Inc | M. Figueroa Richard | Sr. VP and Assistant Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 5,200 | 70,778 (0%) | 0% | 0 | Common Stock | |
| Palo Alto | M. John Donovan | Director | Sale of securities on an exchange or to another person at price $ 330.05 per share. | 12 Jan 2024 | 5,100 | 52,605 (0%) | 0% | 330.1 | 1,683,265 | Common Stock |
| Outset Medical Inc | John L. Brottem | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 5,060 | 249,867 | - | 0 | Common Stock | |
| Greenbrier Cos. Inc | Baker Martin R. | Senior Vice President | 12 Jan 2024 | 5,034 | 53,480 (0%) | 0% | 47 | 236,598 | Common Stock | |
| Core & Main Inc (Class A) | Kimbrough T. Orvin | Director | Sale of securities on an exchange or to another person at price $ 41.06 per share. | 12 Jan 2024 | 5,000 | 9,320 | - | 41.1 | 205,282 | Class A Common Stock |
| Dorian LPG Ltd | Hadjipateras John C. | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 42.58 per share. | 12 Jan 2024 | 5,000 | 1,777,740 (3%) | 0% | 42.6 | 212,900 | Common Shares, $0.01 par value per share |
| Pagerduty Inc | Wilson Owen Howard | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.43 per share. | 12 Jan 2024 | 5,000 | 516,565 (0%) | 0% | 7.4 | 37,150 | Common Stock |
| Pagerduty Inc | Owen Wilson Howard | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 12 Jan 2024 | 5,000 | 511,565 (0%) | 0% | 26.3 | 131,350 | Common Stock |
| Pagerduty Inc | Wilson Owen Howard | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 5,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| CPS Tech Corp | Grant C. Bennett | Director | Gift of securities by or to the insider at price $ 2.30 per share. | 12 Jan 2024 | 5,000 | 1,281,554 (9%) | 0% | 2.3 | 11,500 | Common Stock |
| Cytokinetics Inc | John Henderson T. | Director | Sale of securities on an exchange or to another person at price $ 85.14 per share. | 12 Jan 2024 | 5,000 | 42,632 (0%) | 0% | 85.1 | 425,700 | Common Stock |
| Cytokinetics Inc | Henderson T. John | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 5,000 | 5,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | John Henderson T. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.44 per share. | 12 Jan 2024 | 5,000 | 47,632 (0%) | 0% | 4.4 | 22,200 | Common Stock |
| Kura Sushi USA Inc (Class A) | Takao Brent | See Remarks (a) | Sale of securities on an exchange or to another person at price $ 89.27 per share. | 12 Jan 2024 | 5,000 | 1,687 | - | 89.3 | 446,358 | Class A Common Stock |
| Kura Sushi USA Inc (Class A) | Brent Takao | See Remarks (a) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.94 per share. | 12 Jan 2024 | 5,000 | 6,687 | - | 25.9 | 129,700 | Class A Common Stock |
| Kura Sushi USA Inc (Class A) | Takao Brent | See Remarks (a) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 5,000 | 20,000 | - | - | Option to Purchase Class A Common Stock | |
| Microstrategy Inc (Class A) | Saylor Michael J. | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 5,000 | 355,000 | - | - | Employee Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | J. Michael Saylor | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 121.43 per share. | 12 Jan 2024 | 5,000 | 5,000 (0%) | 0% | 121.4 | 607,150 | Class A Common Stock |
| Core & Main Inc (Class A) | T. Orvin Kimbrough | Director | 12 Jan 2024 | 4,997 | 14,320 | - | 0 | Class A Common Stock | ||
| Core & Main Inc (Class A) | Orvin Kimbrough T. | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 4,997 | 68,704 | - | - | Class B Common Stock and Limited Partnership Interests | |
| Core & Main Inc (Class A) | Kimbrough T. Orvin | Director | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 4,997 | 4,997 | - | - | Class B Common Stock and Limited Partnership Interests | |
| Core & Main Inc (Class A) | T. Orvin Kimbrough | Director | 12 Jan 2024 | 4,997 | 0 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| Coinbase Global Inc (Class A) | Ehrsam Frederick Ernest | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 139.06 per share. | 12 Jan 2024 | 4,900 | 302,180 | - | 139.1 | 681,404 | Class A Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,899 | 233,328 (0%) | 0% | 16.5 | 80,736 | Common Stock |
| AT&T | F. Thaddeus Arroyo | Chief Strategy & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,861 | 260,254 (0%) | 0% | 16.5 | 80,109 | Common Stock |
| Toro Co. | Moeller D. Peter | Group VP, Undg & Spec Construc | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 4,842 | 4,842 (0%) | 0% | 0 | Common Stock | |
| Toro Co. | Moeller Peter D. | Group VP, Undg & Spec Construc | Other type of transaction at price $ 0.00 per share. | 12 Jan 2024 | 4,842 | 0 (0%) | 0% | 0 | Common Stock | |
| Coinbase Global Inc (Class A) | Ehrsam Ernest Frederick | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 137.90 per share. | 12 Jan 2024 | 4,823 | 307,080 | - | 137.9 | 665,097 | Class A Common Stock |
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 12 Jan 2024 | 4,800 | 4,038,016 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 12 Jan 2024 | 4,800 | 4,800 (0%) | 0% | 0 | Class A Common Stock | ||
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,781 | 239,149 (0%) | 0% | 16.5 | 78,791 | Common Stock |
| Leggett & Platt Inc | Glassman Karl G. | Director | Grant, award, or other acquisition of securities at price $ 21.63 per share. | 12 Jan 2024 | 4,728 | 898,509 (0%) | 0% | 21.6 | 102,253 | Common Stock |
| AT&T | Sabrina Sanders | SVP-ChiefActngOfcr&Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 4,723 | 4,722 | - | - | Restricted Stock Units (2022) | |
| AT&T | Sabrina Sanders | SVP-ChiefActngOfcr&Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 4,723 | 115,797 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.63 per share. | 12 Jan 2024 | 4,667 | 106,898 (0%) | 0% | 28.6 | 133,616 | Common Stock |
| Outset Medical Inc | Racine Jean-Olivier | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 4,638 | 274,419 | - | 0 | Common Stock | |
| AT&T | Pascal Desroches | Sr. Exec VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,521 | 340,909 (0%) | 0% | 16.5 | 74,506 | Common Stock |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 4,520 | 229,257 (0%) | 0% | - | Common Stock | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 4,520 | 4,520 | - | - | Restricted Stock Units (2022) | |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,442 | 77,489 (0%) | 0% | 16.5 | 73,204 | Common Stock |
| CorMedix Inc | Erin Mistry | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 12 Jan 2024 | 4,389 | 50,511 (0%) | 0% | 3.5 | 15,230 | Common Stock |
| AT&T | Edward W. Gillespie | SrEVP-Ext & Legal Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,264 | 87,391 (0%) | 0% | 16.5 | 70,271 | Common Stock |
| Velocity Fin Inc | Szczepaniak R. Mark | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 12 Jan 2024 | 4,241 | 103,011 (0%) | 0% | 16.0 | 67,941 | Common Stock |
| Arrowhead Pharma Inc | Hamilton James | Chief Discovery/Trans Medicine | Sale of securities on an exchange or to another person at price $ 36.47 per share. | 12 Jan 2024 | 4,238 | 214,553 (0%) | 0% | 36.5 | 154,560 | Common Stock |
| Nexxen Intl Ltd (ADR) | Ofer Druker | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.54 per share. | 12 Jan 2024 | 4,172 | 4,327,633 (2%) | 0% | 2.5 | 10,601 | Ords 0.01p |
| Home Bancshares Inc | Allison W. John | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jan 2024 | 4,171 | 5,387,982 (3%) | 0% | 0 | Common Stock | |
| Atlassian Corp (Class A) | Cannon-Brookes Michael | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 237.22 per share. | 12 Jan 2024 | 4,151 | 428,532 (0%) | 0% | 237.2 | 984,694 | Class A Common Stock |
| Atlassian Corp (Class A) | Farquhar Scott | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 237.22 per share. | 12 Jan 2024 | 4,151 | 428,532 (0%) | 0% | 237.2 | 984,694 | Class A Common Stock |
| Salesforce | Benioff Marc | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 273.50 per share. | 12 Jan 2024 | 4,147 | 13,806,621 (1%) | 0% | 273.5 | 1,134,204 | Common Stock |
| American International | Glazer E. Rose Marie | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.50 per share. | 12 Jan 2024 | 4,144 | 29,113 (0%) | 0% | 67.5 | 279,720 | Common Stock |
| Interface Inc | James Poppens | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.04 per share. | 12 Jan 2024 | 4,071 | 122,278 (0%) | 0% | 12.0 | 49,015 | Common Stock |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,041 | 248,649 (0%) | 0% | 16.5 | 66,596 | Common Stock |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 4,001 | 114,618 (0%) | 0% | 16.5 | 65,936 | Common Stock |
| DexCom | Jake Leach | EVP Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 12 Jan 2024 | 3,978 | 262,499 (0%) | 0% | 123.6 | 491,819 | Common Stock |
| Leggett & Platt Inc | G. Glassman Karl | Director | Grant, award, or other acquisition of securities at price $ 20.35 per share. | 12 Jan 2024 | 3,852 | 902,361 (0%) | 0% | 20.4 | 78,404 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 271.70 per share. | 12 Jan 2024 | 3,850 | 13,817,316 (1%) | 0% | 271.7 | 1,046,052 | Common Stock |
| AT&T | Sabrina Sanders | SVP-ChiefActngOfcr&Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 3,777 | 0 | - | - | Restricted Stock Units (2021) | |
| AT&T | Sabrina Sanders | SVP-ChiefActngOfcr&Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 3,777 | 112,194 (0%) | 0% | - | Common Stock | |
| AT&T | Jeremy Alan Legg | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 3,774 | 224,737 (0%) | 0% | 16.5 | 62,196 | Common Stock |
| Arrowhead Pharma Inc | James Hamilton | Chief Discovery/Trans Medicine | Sale of securities on an exchange or to another person at price $ 37.37 per share. | 12 Jan 2024 | 3,702 | 210,851 (0%) | 0% | 37.4 | 138,344 | Common Stock |
| Velocity Fin Inc | L. Fiona Tam | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 12 Jan 2024 | 3,645 | 31,803 (0%) | 0% | 16.0 | 58,393 | Common Stock |
| Outset Medical Inc | L. Porter Stacey | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 3,586 | 62,216 | - | 0 | Common Stock | |
| Palo Alto | Donovan John M. | Director | Sale of securities on an exchange or to another person at price $ 330.00 per share. | 12 Jan 2024 | 3,500 | 33,352 (0%) | 0% | 330.0 | 1,155,011 | Common Stock |
| Palo Alto | M. John Donovan | Director | Sale of securities on an exchange or to another person at price $ 330.05 per share. | 12 Jan 2024 | 3,500 | 57,705 (0%) | 0% | 330.1 | 1,155,179 | Common Stock |
| AT&T | Kellyn Smith Kenny | Chief Marketing & Growth Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.48 per share. | 12 Jan 2024 | 3,445 | 138,435 (0%) | 0% | 16.5 | 56,774 | Common Stock |
| Kilroy Realty Corp | A. Robert Paratte | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 12 Jan 2024 | 3,436 | 41,065 (0%) | 0% | 40.5 | 139,158 | Common stock, par value $0.01 per share |
| CuriosityStream Inc - Ordinary Shares- Class A | Cudahy Tia | COO, Gen Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.56 per share. | 12 Jan 2024 | 3,397 | 41,580 | - | 0.6 | 1,899 | Common Stock |
| One Liberty Properties Inc | J. Lovejoy Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 3,350 | 91,449 (0%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Charles Biederman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 3,350 | 46,780 (0%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | A. Karen Till | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 3,350 | 16,498 (0%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Gellert Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 3,350 | 11,650 (0%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Leor Siri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 3,350 | 31,628 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.